Date published: 2026-2-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Propionylpromazine hydrochloride (CAS 7681-67-6)

4.0(1)
Write a reviewAsk a question

Alternate Names:
Propiopromazine hydrochloride
Application:
CAS Number:
7681-67-6
Purity:
≥93%
Molecular Weight:
376.94
Molecular Formula:
C20H24N2OS•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Propionylpromazine hydrochloride is a dopamine receptor antagonist. It acts by blocking the dopamine receptors in the central nervous system. This blockade results in a decrease in the effects of dopamine, leading to sedative and antiemetic effects. Propionylpromazine hydrochloride may possess antipsychotic properties due to its ability to modulate dopamine neurotransmission. Its mechanism of action involves inhibiting the release of dopamine and altering the sensitivity of dopamine receptors in the brain. Propionylpromazine Hydrochloride also exhibits anticholinergic and alpha-adrenergic blocking properties, contributing to its pharmacological effects.


Propionylpromazine hydrochloride (CAS 7681-67-6) References

  1. Determination of propionylpromazine hydrochloride in formulation matrixes using reversed-phase ion-pair small bore liquid chromatography.  |  Hurlbut, DB., et al. 1999. J AOAC Int. 82: 1321-8. PMID: 10589483
  2. Development of a rapid screening test for veterinary sedatives and the beta-blocker carazolol in porcine kidney by ELISA.  |  Cooper, J., et al. 2004. Analyst. 129: 169-74. PMID: 14752562
  3. Development of a solid phase extraction method for simultaneous determination of corticoids and tranquilizers in serum samples.  |  Quintana, MC., et al. 2004. J Sep Sci. 27: 53-8. PMID: 15335058
  4. Stability of the tranquilizer drug propionylpromazine hydrochloride in formulated products.  |  Primus, TM., et al. 2005. Pest Manag Sci. 61: 605-11. PMID: 15668921
  5. Inhaled Nitric Oxide Counterbalances ET-1 Dependent Pulmonary Hypertension and Bronchoconstriction in the Pig.  |  Clement, MG. and Dimori, M. 1994. Mediators Inflamm. 3: 131-5. PMID: 18472931
  6. Role of endogenous nitric oxide on PAF-induced vascular and respiratory effects.  |  Clement, M. and Albertini, M. 1995. Mediators Inflamm. 4: 124-9. PMID: 18475628
  7. Inhibition of morphine-induced cAMP overshoot: a cell-based assay model in a high-throughput format.  |  Xia, M., et al. 2011. Cell Mol Neurobiol. 31: 901-7. PMID: 21598037
  8. A 'genome-to-lead' approach for insecticide discovery: pharmacological characterization and screening of Aedes aegypti D(1)-like dopamine receptors.  |  Meyer, JM., et al. 2012. PLoS Negl Trop Dis. 6: e1478. PMID: 22292096
  9. A pharmacological network for lifespan extension in Caenorhabditis elegans.  |  Ye, X., et al. 2014. Aging Cell. 13: 206-15. PMID: 24134630
  10. Asenapine modulates nitric oxide release and calcium movements in cardiomyoblasts.  |  Grossini, E., et al. 2016. J Pharmacol Pharmacother. 7: 6-14. PMID: 27127388
  11. A cell-based quantitative high-throughput image screening identified novel autophagy modulators.  |  Li, Y., et al. 2016. Pharmacol Res. 110: 35-49. PMID: 27168224
  12. Metabolism and pharmacokinetic studies of propionylpromazine in horses.  |  Park, J., et al. 1989. J Chromatogr. 489: 313-21. PMID: 2753955
  13. Effect of phenothiazine compounds on the secondary structure and fibrillogenesis of poly-l-lysine.  |  Cieślik-Boczula, K. 2019. Spectrochim Acta A Mol Biomol Spectrosc. 216: 15-24. PMID: 30870786
  14. Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroids.  |  Woodruff, G., et al. 2020. PLoS One. 15: e0240991. PMID: 33091047
  15. Analysis of propionylpromazine and its metabolites in horse urine.  |  Dewey, EA. and Maylin, GA. 1984. Cornell Vet. 74: 38-49. PMID: 6705538

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Propionylpromazine hydrochloride, 100 mg

sc-250790
100 mg
$84.00